Literature DB >> 24736520

Changes in alexithymia following psychological intervention: a review.

Kristjana Cameron1, John Ogrodniczuk, George Hadjipavlou.   

Abstract

Alexithymia, a deficit characterized by difficulties identifying, differentiating, and articulating emotions, is associated with significant physical and mental health impairment. It is generally accepted that alexithymia has a negative impact on a variety of physical and mental health treatments. Less clear is the extent to which alexithymia itself can be modified. In this article we review studies that have examined the effects of psychological interventions on alexithymia. Taken together, findings from investigations included in this review suggest that alexithymia is partly modifiable with therapeutic interventions. Studies that directly targeted alexithymic symptoms tended to report significant reductions in alexithymia scores following treatment, whereas studies that measured changes in alexithymia but did not employ any psychological interventions specifically intended to treat alexithymia had more inconsistent results. We close by considering the practical implications of the findings, and by offering suggestions for future research.

Entities:  

Mesh:

Year:  2014        PMID: 24736520     DOI: 10.1097/HRP.0000000000000036

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  32 in total

1.  Affect labeling and other aspects of emotional experiences in relation to alexithymia following standardized emotion inductions.

Authors:  Rachel V Aaron; Matthew A Snodgress; Scott D Blain; Sohee Park
Journal:  Psychiatry Res       Date:  2018-02-05       Impact factor: 3.222

2.  Measuring Alexithymia via Trait Approach-I: A Alexithymia Scale Item Selection and Formation of Factor Structure.

Authors:  Arkun Tatar; Gaye Saltukoğlu; Seda Alioğlu; Sümeyye Çimen; Hülya Güven; Çağla Ebru Ay
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

3.  The Impact of Resilience, Alexithymia and Subjectively Perceived Helplessness of Myocardial Infarction on the Risk of Posttraumatic Stress.

Authors:  Sandra Van der Auwera; Hans Jörgen Grabe; Kevin Kirchner; Hartmut Brauer
Journal:  J Clin Psychol Med Settings       Date:  2022-02-15

4.  Impact of Alexithymia on the Lipid Profile in Major Depressed Individuals.

Authors:  Camille Point; Benjamin Wacquier; Marjorie Dosogne; Mohammed Al Faker; Hadrien Willame; Gwenolé Loas; Matthieu Hein
Journal:  J Lipids       Date:  2022-06-16

5.  Aggression, Alexithymia and Sense of Coherence in a Sample of Schizophrenic Outpatients.

Authors:  Argyro Pachi; Athanasios Tselebis; Ioannis Ilias; Effrosyni Tsomaka; Styliani Maria Papageorgiou; Spyros Baras; Evgenia Kavouria; Konstantinos Giotakis
Journal:  Healthcare (Basel)       Date:  2022-06-10

6.  Investigating the role of alexithymia on the empathic deficits found in schizotypy and autism spectrum traits.

Authors:  Rachel V Aaron; Taylor L Benson; Sohee Park
Journal:  Pers Individ Dif       Date:  2015-01-24

Review 7.  Atypical interoception as a common risk factor for psychopathology: A review.

Authors:  Rebecca Brewer; Jennifer Murphy; Geoffrey Bird
Journal:  Neurosci Biobehav Rev       Date:  2021-08-03       Impact factor: 8.989

8.  Alexithymia in individuals with chronic pain and its relation to pain intensity, physical interference, depression, and anxiety: a systematic review and meta-analysis.

Authors:  Rachel V Aaron; Emma A Fisher; Rocio de la Vega; Mark A Lumley; Tonya M Palermo
Journal:  Pain       Date:  2019-05       Impact factor: 7.926

9.  Alexithymia Is Associated With Deficits in Visual Search for Emotional Faces in Clinical Depression.

Authors:  Thomas Suslow; Vivien Günther; Tilman Hensch; Anette Kersting; Charlott Maria Bodenschatz
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

Review 10.  Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.

Authors:  C Elise Kleyn; Peter S Talbot; Nehal N Mehta; Francesca Sampogna; Chris Bundy; Darren M Ashcroft; Alexa B Kimball; Peter C M van de Kerkhof; Christopher E M Griffiths; Fernando Valenzuela; Joelle M van der Walt; Tsion Aberra; Lluís Puig
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.